Industry Therapeutic Update from Eisai: The Time is Now: Urgent Need for a Patient-Centered Care Framework in Alzheimer's
Faculty Disclosures
Marwan N. Sabbagh, MD, FAAN
Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Julie B. Schwartzbard, MD, FAAN
Dr. Schwartzbard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Schwartzbard has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NFL Concussion Settlement Program. Dr. Schwartzbard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Schwartzbard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Schwartzbard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Schwartzbard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Schwartzbard has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Several. Dr. Schwartzbard has received research support from Lilly. Dr. Schwartzbard has received research support from Eisai. Dr. Schwartzbard has received research support from TauRx. Dr. Schwartzbard has received research support from Sparc. Dr. Schwartzbard has received research support from Roche. Dr. Schwartzbard has received research support from Cerevel. Dr. Schwartzbard has received research support from Amneal. Dr. Schwartzbard has received research support from Neuroderm.